Healthcare - Biotechnology - NASDAQ - US
$ 4.5
0.897 %
$ 61.2 M
Market Cap
-17.31
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
9.12%
EBIT
Estimate
16.37%
Net Income
Estimate
25.99%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Champions Oncology, Inc.
CSBR has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart CSBR
EBIT FORECAST
EBIT Forecast Chart CSBR
NET INCOME FORECAST
Net Income Chart CSBR